Skip to main content
DexCom, Inc. (BIT:1DXCM)
Italy flag Italy · Delayed Price · Currency is EUR
52.80
+1.00 (1.93%)
At close: Apr 27, 2026

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of EUR 19.54 billion. The enterprise value is 19.03 billion.

Market Cap 19.54B
Enterprise Value 19.03B

Important Dates

The next confirmed earnings date is Thursday, April 30, 2026.

Earnings Date Apr 30, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 385.87M
Shares Outstanding n/a
Shares Change (YoY) -1.75%
Shares Change (QoQ) -2.09%
Owned by Insiders (%) 0.37%
Owned by Institutions (%) 97.10%
Float 383.95M

Valuation Ratios

The trailing PE ratio is 27.44 and the forward PE ratio is 23.34.

PE Ratio 27.44
Forward PE 23.34
PS Ratio 4.92
PB Ratio 8.36
P/TBV Ratio 8.65
P/FCF Ratio 21.30
P/OCF Ratio 15.93
PEG Ratio n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.59, with an EV/FCF ratio of 20.74.

EV / Earnings 26.71
EV / Sales 4.78
EV / EBITDA 18.59
EV / EBIT 24.44
EV / FCF 20.74

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.51.

Current Ratio 1.88
Quick Ratio 1.53
Debt / Equity 0.51
Debt / EBITDA 1.17
Debt / FCF 1.30
Interest Coverage 49.83

Financial Efficiency

Return on equity (ROE) is 34.50% and return on invested capital (ROIC) is 33.98%.

Return on Equity (ROE) 34.50%
Return on Assets (ROA) 8.89%
Return on Invested Capital (ROIC) 33.98%
Return on Capital Employed (ROCE) 21.72%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 359,333
Profits Per Employee 64,459
Employee Count 11,050
Asset Turnover 0.73
Inventory Turnover 3.18

Taxes

In the past 12 months, DexCom has paid 214.71 million in taxes.

Income Tax 214.71M
Effective Tax Rate 23.16%

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 57.32
200-Day Moving Average 59.93
Relative Strength Index (RSI) 35.68
Average Volume (20 Days) 188

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 3.44

Income Statement

In the last 12 months, DexCom had revenue of EUR 3.97 billion and earned 712.28 million in profits. Earnings per share was 1.78.

Revenue 3.97B
Gross Profit 2.39B
Operating Income 776.58M
Pretax Income 926.99M
Net Income 712.28M
EBITDA 991.04M
EBIT 776.58M
Earnings Per Share (EPS) 1.78

Balance Sheet

The company has 1.70 billion in cash and 1.19 billion in debt, giving a net cash position of 512.98 million.

Cash & Cash Equivalents 1.70B
Total Debt 1.19B
Net Cash 512.98M
Net Cash Per Share n/a
Equity (Book Value) 2.34B
Book Value Per Share 6.08
Working Capital 1.61B

Cash Flow

In the last 12 months, operating cash flow was 1.23 billion and capital expenditures -309.59 million, giving a free cash flow of 917.45 million.

Operating Cash Flow 1.23B
Capital Expenditures -309.59M
Depreciation & Amortization 214.98M
Net Borrowing -1.03B
Free Cash Flow 917.45M
FCF Per Share n/a

Margins

Gross margin is 60.10%, with operating and profit margins of 19.56% and 17.94%.

Gross Margin 60.10%
Operating Margin 19.56%
Pretax Margin 23.35%
Profit Margin 17.94%
EBITDA Margin 24.96%
EBIT Margin 19.56%
FCF Margin 23.11%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 1.75%
Shareholder Yield 1.75%
Earnings Yield 3.64%
FCF Yield 4.69%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

DexCom has an Altman Z-Score of 7.06 and a Piotroski F-Score of 6.

Altman Z-Score 7.06
Piotroski F-Score 6